Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy.
Maria J StangouSmaragdi MarinakiEvangelos PapachristouKyriaki KolovouErasmia SambaniSynodi ZerbalaPanagiota PapadeaOlga BalafaKarolos-Pavlos RapsomanikisAimilios AndrikosPanagiota ManolakakiDorothea PapadopoulouEfstathios MitsopoulosHelen LiakouParaskevi-Evi AndronikidiVasiliki ChoulitoudiGeorge MoustakasDimitra GalitsiouEugene DafnisKonstantinos StylianouIoannis StefanidisSpyridon GolfinopoulosStylianos PanagoutsosMaria TsilivigkouApostolos PapadogianakisIoannis TzanakisAthanasios SioulisDimitrios VlachakosEirini GrapsaSophia SpaiaNikolaos KaperonisChristos PaliourasChristos DioudisFani PapoulidouTheofanis ApostolouChristos IatrouIoannis BoletisDimitrios GoumenosAikaperini PapagianniPublished in: PloS one (2019)
Long term follow up showed that administration of Cyclo in PMN is followed by better preservation of renal function, increased response rate and less frequent relapses, compared to CNIs.
Keyphrases